Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03502785
Title INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Inovio Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Cancer Center Phoenix Arizona 85054 United States Details
H. Lee Moffitt Cancer Center & Research Institute, Inc. Tampa Florida 33612 United States Details
Johns Hopkins University School of Medicine Baltimore Maryland 21287 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Washington University School of Medicine in St. Louis Saint Louis Missouri 63110 United States Details
New York University Langone Medical Center - Perlmutter Cancer Center New York New York 10016 United States Details
Columbia University, Herbert Irving Comprehensive Cancer Center New York New York 10032 United States Details
University of North Carolina School of Medicine Chapel Hill North Carolina 27599 United States Details
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15232 United States Details
Greenville Memorial Hospital Greenville South Carolina 29615 United States Details
Inova Melanoma and Skin Cancer Center Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field